PubMed COVID-19 Clinical Care

INTRODUCTION: Mucormycosis has emerged as one of the most fatal complications arising due to COVID-19, though it has to be mentioned that the disease is capable of causing serious illness even on its own.

CONCLUSION: SAB remains a challenging infection that is amplified by the pandemic. Older age and ICU admission are significant mortality predictors. In settings with a high prevalence of MRSA, factors like age, sex, and quality of care outweigh

Efficient recruitment of eligible participants is a significant challenge for clinical research studies. This challenge was exacerbated during the COVID-19 pandemic when in-person recruitment was not an option. In 2020, the University of Minnesota

[This corrects the article DOI: 10.1016/j.ijregi.2021.10.008.].

[This corrects the article DOI: 10.1016/j.ijregi.2021.10.008.].

CONCLUSIONS: Findings demonstrate the underlying importance of judgment variables for vaccine choices and uptake, suggesting that vaccine education and messaging might target varying judgment profiles to improve uptake. These methods could also be

While industry and regulators' interest in decentralized clinical trials (DCTs) is long-standing, the Covid-19 pandemic accelerated and broadened the adoption and experience with these trials. The key idea in decentralization is bringing the clinical

Assessing the impact of coronavirus disease 2019 (COVID-19) reveals unique challenges for pregnant women, who experience distinct clinical manifestations and health outcomes compared to their non-pregnant counterparts. We aimed to evaluate the

CONCLUSIONS: Tele-visit delivered outpatient IBD care is not associated with higher risk of IBD-related hospitalization. These findings may reassure clinicians that tele-visit-delivered outpatient care is appropriate for patients with complex chronic

[This corrects the article DOI: 10.1016/j.ijregi.2021.10.008.].